Quick Answer
PLIANT THERAPEUTICS, INC. reported Net Income of -$149.34 million for fiscal year 2025.
PLIANT THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$149.34M | +29.0% |
| 2024 | -$210.30M | -30.4% |
| 2023 | -$161.34M | -30.8% |
| 2022 | -$123.32M | -26.8% |
| 2021 | -$97.26M | -134.2% |
| 2020 | -$41.53M | -6482.1% |
| 2019 | -$631.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.30M | +54.5% | +39.3% |
| June 30, 2025 | -$43.30M | +22.5% | +22.9% |
| March 31, 2025 | -$56.17M | -19.6% | +2.8% |
| September 30, 2024 | -$57.76M | -39.2% | -3.4% |
| June 30, 2024 | -$55.85M | -35.6% | -19.0% |
| March 31, 2024 | -$46.95M | -25.1% | -13.2% |
| September 30, 2023 | -$41.49M | -35.5% | -0.7% |
| June 30, 2023 | -$41.19M | -39.4% | -9.7% |
- PLIANT THERAPEUTICS, INC. showed an increase of +29.0% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, PLIANT THERAPEUTICS, INC.’s net income has declined by 23567.8% (from -$631.0 thousand to -$149.34 million).
- The most recent figure is from PLIANT THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: